Real life experience on the use of Remdesivir in patients admitted to COVID-19 in two referral Italian hospital: a propensity score matched analysis
Sign Up to like & getrecommendations! Published in 2024 at "Scientific Reports"
DOI: 10.1038/s41598-024-59957-w
Abstract: Remdesivir (RDV) was the first Food and Drug Administration (FDA)-approved medication for COVID-19, with discordant data on efficacy in reducing mortality risk and disease progression. In the context of a dynamic and rapidly changing pandemic… read more here.
Keywords: use remdesivir; propensity score; remdesivir; covid ... See more keywords
Potential kidney damage associated with the use of remdesivir for COVID-19: analysis of a pharmacovigilance database.
Sign Up to like & getrecommendations! Published in 2021 at "Cadernos de saude publica"
DOI: 10.1590/0102-311x00077721
Abstract: The U.S. Food and Drug Administration (FDA) has stated that the prescription of remdesivir should be cautious for patients with estimated glomerular filtration rate (eGFR) < 30 and some studies reported risk of adverse renal… read more here.
Keywords: renal urinary; remdesivir; pharmacovigilance database; use remdesivir ... See more keywords